ArticlePDF Available

A Cellular MicroRNA Mediates Antiviral Defense in Human Cells

Authors:

Abstract and Figures

In eukaryotes, 21- to 24-nucleotide-long RNAs engage in sequence-specific interactions that inhibit gene expression by RNA silencing. This process has regulatory roles involving microRNAs and, in plants and insects, it also forms the basis of a defense mechanism directed by small interfering RNAs that derive from replicative or integrated viral genomes. We show that a cellular microRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses microRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities. Therefore, through fortuitous recognition of foreign nucleic acids, cellular microRNAs have direct antiviral effects in addition to their regulatory functions.
Content may be subject to copyright.
hand, 466 distinct homologs of the light-driven
proton pump bacteriorhodopsin are found in the
surface waters of the Sargasso Sea, whereas none
are found in the deep-sea whale falls or in soil.
The analysis of operons likewise reveals
similarities and differences in functional systems
(Fig. 4, upper right) that suggest features of the
environments. The most discriminating operons
tend to be systems for the transport of ions and
inorganic components, highlighting their impor-
tance for survival and adaptation. With respect
to ionic and osmotic homeostasis, for example,
the two maritime environments are similar—
both show a strong enrichment in operons that
contain transporters for organic osmolites and
sodium ion exporters coupled to oxidative phos-
phorylation. The soil sample, on the other hand,
has a strong enrichment in operons responsible
for active potassium channeling. These biases
nicely reflect the relative abundance of these
ions in the respective environments: Whereas
typical ocean water contains considerably more
sodium ions than potassium, the soil sample
examined here containedhighpotassiumand
low sodium concentrations (13).
Examination of higher order processes
reveals known differences in energy production
(e.g., photosynthesis in the oligotrophic waters
of the Sargasso Sea and starch and sucrose
metabolism in soil) (7) or population density
and interspecies communication Eoverrepresen-
tation of conjugation systems, plasmids, and
antibiotic biosynthesis in soil (Fig. 4, lower
left)^ (22). The broad functional COG catego-
ries, on the other hand, primarily suggest
differences in genome size and phylogenetic
composition (13).
Notably, many uncharacterized genes and
processes are among the most overrepresented
categories in each sample. This hints at an
abundance of previously unknown functional
systems, specific to each environment, whose
occurrence patterns may offer useful guidance
for further, more directed experimental and com-
putational investigations. More extensive
sampling in both time and space will reveal
which features are broadly distributed within a
given environment and which are unique to the
places and times sampled here. Nonetheless, this
analysis of genes and functional modules in
environments reveals expected contrasts, hints at
certain nutrition conditions, and points to novel
genes and systems contributing to a particular
Blife-style[ or environmental interaction.
The predicted metaproteome, based on
fragmented sequence data, is sufficient to iden-
tify functional fingerprints that can provide
insight into the environments from which
microbial communities originate. Information
derived from extension of the comparative meta-
genomic analyses performed here could be used
to predict features of the sampled environments
such as energy sources or even pollution levels.
At the same time, the environment-specific dis-
tribution of unknown orthologous groups and
operons offers exciting avenues for further inves-
tigation. Just as the incomplete but information-
dense data represented by expressed sequence
tags have provided useful insights into vari-
ous organisms and cell types, EGT-based eco-
genomic surveys represent a practical and
uniquely informative means for understanding
microbial communities and their environments.
References and Notes
1. E. F. DeLong, N. R. Pace, Syst. Biol. 50, 470 (2001).
2. P. Hugenholtz, Genome Biol 3, REVIEWS0003 (2002).
3. M. R. Liles, B. F. Manske, S. B. Bintrim, J. Handelsman,
R. M. Goodman, Appl. Environ . Mic robiol. 69, 2684 (2003).
4. O. Beja et al., Science 289, 1902 (2000).
5. A. H. Treusch et al., Appl. Environ. Microbiol. 6, 970
(2004).
6. G. W. Tyson et al., Nature 428, 37 (2004).
7. J. C. Venter et al., Science 304, 66 (2004).
8. V. Torsvik, L. Ovreas, T. F. Thingstad, Science 296,
1064 (2002).
9. Y. A. Goo et al., BMC Genomics 5, 3 (2004).
10. C. R. Smith, A. R. Baco, in Oceanography and Marine
Biology: An Annual Review, R. N. Gibson, R. J. A.
Atkinson, Eds. (Taylor & Francis, London, 2003), vol.
41, pp. 311–354.
11. J. B. Hughes, J. J. Hellmann, T. H. Ricketts, B. J.
Bohannan, Appl. Environ. Microbiol. 67, 4399 (2001).
12. R. K. Colwell, personal communications (1994–2004).
13. Supplementary online material.
14. R. Overbeek, M. Fonstein, M. D’Souza, G. D. Pusch, N.
Maltsev, Proc. Natl. Acad. Sci. U.S.A. 96, 2896 (1999).
15. R. L. Tatusov et al., BMC Bioinformatics 4, 41 (2003).
16. C. von Mering et al., Nucleic Acids Res. 33, D433 (2005).
17. A. Bateman et al., Nucleic Acids Res. 32 (Database
special issue), D138 (2004).
18. S. K. Rhee et al., Appl . Environ. Microbiol. 70, 4303 (2004).
19. D. E. Robertson et al., Appl. Environ. Microbiol. 70,
2429 (2004).
20. C. von Mering et al., Proc. Natl. Acad. Sci. U.S.A.
100, 15428 (2003).
21. M. Kanehisa, S. Goto, S. Kawashima, Y. Okuno, M.
Hattori, Nucleic Acids Res. 32 (Database special
issue), D277 (2004).
22. R. Daniel, Curr. Opin. Biotechnol. 15, 199 (2004).
23. http://string.embl.de/metagenome_comp_suppl/
24. This work was performed under the auspices of the
DOE’s Office of Science, Biological and Environmental
Research Program; the University of California, Law-
rence Livermore National Laboratory, under contract
no. W-7405-Eng-48; Lawrence Berkeley National
Laboratory under contract no. DE-AC03-76SF00098;
and Los Alamos National Laboratory under contract
no. W-7405-ENG-36. S.G.T. was supported by grant
no. THL007279F, an NIH National Research Service
Award (NRSA) Training and Fellowship grant to E.R.
K.C. was supported by NSF grant no. EF 03-31494.
Sequencing of the environmental libraries was per-
formed under a license agreement with Diversa (J. R.
Short, U.S. patent no. 6455254). We gratefully ac-
knowledge the efforts of C. Baptista, L. Christoffersen,
J. Garcia, K. Li, J. Ritter, P. Sammon, S. Wells, D.
Whitney, J. Eads, T. Richardson, M. Noordewier, and L.
Bibbs. We thank C. Smith for providing the whale fall
samples; K. Remington for providing Sargasso Sea
sample information; N. Ivanova, N. Kyrpides, and
members of the Rubin laboratory for helpful com-
ments on the manuscript; and J. Chapman, I. Grigoriev,
E. Szeto, J. Korbel, T. Doerks, K. Foerstner, E.
Harrington, and M. Krupp for assistance with data
processing and analysis. These Whole Genome
Shotgun projects have been deposited with the DNA
Data Bank of Japan, the European Molecular Biology
Laboratory (EMBL) Nucleotide Sequence Database, and
the GenBank in collaboration (DDBJ/EMBL/GenBank)
under the project accessions AAFX00000000 (soil),
AAFY00000000 (whale fall 1), AAFZ00000000 (whale
fall 2), and AAGA00000000 (whale fall 3). For each
project, the version described in this paper is the
first version, AAFX01000000, AAFY01000000,
AAFZ01000000, and AAGA01000000. The 16S rRNA
sequences from the soil and three whale fall samples
have been deposited under GenBank accession nos.
AY921654 to AY922252. The metagenomic data will
also be incorporated into the U.S. Department of
Energy Joint Genome Institute Integrated Microbial
Genomes system (www.jgi.doe.gov/) to facilitate
detailed comparative analysis of the data in the context
of all publicly available complete microbial genomes.
Supporting Online Material
www.sciencemag.org/cgi/content/full/308/5721/554/
DC1
Materials and Methods
Figs. S1 to S7
References and Notes
23 November 2004; accepted 4 February 2005
10.1126/science.1107851
A Cellular MicroRNA Mediates
Antiviral Defense in Human Cells
Charles-Henri Lecellier,
1
*
Patrice Dunoyer,
1
Khalil Arar,
2
Jacqueline Lehmann-Che,
3
Stephanie Eyquem,
4
Christophe Himber,
1
Ali Saı
¨
b,
3
Olivier Voinnet
1
*
In eukaryotes, 21- to 24-nucleotide-long RNAs engage in sequence-specific
interactions that inhibit gene expression by RNA silencing. This process has
regulatory roles involving microRNAs and, in plants and insects, it also forms
the basis of a defense mechanism directed by small interfering RNAs that
derive from replicative or integrated viral genomes. We show that a cellular
microRNA effectively restricts the accumulation of the retrovirus primate
foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas,
that suppresses microRNA-directed functions in mammalian cells and displays
cross-kingdom antisilencing activities. Therefore, through fortuitous recogni-
tion of foreign nucleic acids, cellular microRNAs have direct antiviral effects in
addition to their regulatory functions.
In plants and insects, viral double-stranded
RNA is processed into small interfering RNAs
(siRNAs) by the ribonuclease (RNase) III en-
zyme Dicer. These siRNAs are incorporated
into the RNA-induced silencing complex to
target the pathogen_s genome for destruc-
tion (1, 2). Plant and insect viruses can
counter this defense with silencing suppres-
R EPORTS
www.sciencemag.org SCIENCE VOL 308 22 APRIL 2005
557
sor proteins, which often have adverse side
effects on microRNA (miRNA) functions
(3, 4). Although undisputed in plants and
insects, a defensive role for RNA silencing
in vertebrates has not been demonstrated.
Virus-derived small RNAs have not been
detected in infected vertebrate cells, with
the exception of miRNAs produced by the
Epstein-Barr virus, but the role of those
molecules remains unclear (5). Moreover,
some mammalian virus-encoded proteins that
suppress RNA silencing have only been
investigated in heterologous systems (6).
Because RNA silencing suppresses mobili-
zation of endogenous retroviruses in plants,
yeast, worms, and flies (7), we reasoned that
retrotransposition of mammalian exogenous
viruses might also be subject to this process.
Therefore, we studied the primate foamy
virus type 1 (PFV-1), a complex retrovirus
(akin to human immunodeficiency virus) that,
in addition to the Gag, Pol, and Env proteins,
produces two auxiliary factors, Bet and
Tas, from the internal promoter (IP) (Fig.
1A) (8).
PFV-1 accumulation was strongly en-
hanced in 293T cells expressing the P19
silencing suppressor (Fig. 1B). This sug-
gested that a siRNA and/or miRNA pathway
limits PFV-1 replication in human cells, be-
cause P19 specifically binds to and inacti-
vates both types of small RNAs (4, 9, 10).
Viral sequences spanning the 12-kb-long
PFV-1 genome (Fig. 1A) were fused to the
3 untranslated region (UTR) of a green flu-
orescent protein (GFP)–tagged reporter gene,
1
CNRS Unite
´
Propre de Recherche (UPR) 2357, Insti-
tut de Biologie Mole
´
culaire des Plantes, 12 rue du
Ge
´
ne
´
ral Zimmer, 67084 Strasbourg Cedex, France.
2
Proligo, Paris, France.
3
CNRS UPR9051, Ho
ˆ
pital St-
Louis, Paris, France.
4
INSERM U462, Ho
ˆ
pital St-Louis,
Paris, France.
*To whom correspondence should be addressed.
E-mail: charles.lecellier@infobiogen.fr (C.-H.L.); olivier.
voinnet@ibmp-ulp.u-strasbg.fr (O.V.)
Fig. 1. RNA silencing
limits PFV-1 accumu-
lation in mammalian
cells. (A) Schematic of
the PFV-1 genome. Bent
arrows indicate the start
of transcription between
the 5-proximal long-
terminal repeat (LTR)
and the IP. Viral se-
quences (F1 to F10) used
for GFP transcriptional
fusions are indicated.
(B) mRNA accumula-
tion from PFV-1 in 293T
cells that do (þ)ordo
not (–) stably express
the P19 protein. Cells
were harvested 48 hours
after transfection. North-
ern analysis confirms
P19 expression. rRNA,
ethidium bromide stain-
ing of ribosomal RNA;
NI, noninfected. (C) The
GFP sensors F1 to F11 were transfected together with (þ) or in the absence of (–) PFV-1. Their
expression was assayed 48 hours later by Northern (first upper panel) and Western (fourth panel)
analysis. (Second upper panel) PFV-1 RNA accumulation. (Bottom) Staining of total protein for
loading control. Relative RNA or protein accumulation is shown at the bottom of each panel, with
control levels arbitrarily set to 1.
Fig. 2. miR-32 effectively
limits PFV-1 replication. (A)
Position of the computa-
tionally predicted miR-32
target relative to PFV-1
transcripts. (B) The miR-
32 target sequence or a
mutated form thereof (–)
was fused to the 3UTR
of a GFP reporter gene (þ).
Constructs were trans-
fected in HeLa cells and
harvested 48 hours later.
GFP and GFP mRNA ac-
cumulation were assess-
ed by Western (top) and
Northern (bottom) analy-
sis. (C) HeLa cells were
transfected with PFV-1 to-
gether with LNAs (10 nM)
directed against miR-32 or
miR-23. Total RNA was
extracted 48 hours after
transfection and subjected
to Northern analysis. (D)
PFV-1 was transfected in
HeLa cells (transfection 1).
Separate cells were trans-
fected with a luciferase-
based reporter (Luc) driven
by the PFV-1 IP, which is
activated by the transacti-
vator Tas (transfection 2).
Transfections 1 and 2 were mixed 24 hours later and further cocultured for 48
hours. Luciferase expression in cells from transfection 2, resulting from their
infection by virions released from transfection 1, was then quantified. hpt,
hours post-transfection. (E) The miR-32 target sequence within PFV-1D32
contains two synonymous mutations (arrows). Northern analysis of mutant
and wild-type virus mRNAs was carried out 48 hours after transfection.
R EPORTS
22 APRIL 2005 VOL 308 SCIENCE www.sciencemag.org
558
and the resulting constructs (F1 to F11) were
cotransfected with PFV-1 into baby hamster
kidney (BHK) 21 cells. Any viral-derived
siRNA would induce RNA silencing of the
corresponding reporter fusions, diagnosed as
reduced GFP mRNA accumulation. However,
the mRNA levels from those constructs were
similar in noninfected and infected cells (Fig.
1C). Use of a highly sensitive RNase pro-
tection assay likewise failed to provide evi-
dence for viral-derived siRNAs (fig. S1).
The GFP levels from fusion F11 were dis-
proportionably reduced compared to the accu-
mulation of the F11 mRNA (Fig. 1C). They
were also reduced compared to the GFP levels
from constructs F2 and F10. Although a pos-
sible result of intrinsic protein instability, the
effect was reminiscent of the translational in-
hibition directed by animal miRNAs (11).
However, it was independent of the presence
or absence of PFV-1 (Fig. 1C), suggesting that
any miRNA involvement was likely cellular
rather than viral. Using the DIANA-microT
algorithm (12), we found a high probability hit
(free energy of –21.0 kcal/mol) between the
PFV-1 F11 sequence and the human miR-32
(Fig. 2A) (13). The predicted miR-32 target
sequence was sufficient to promote transla-
tion inhibition of the GFP mRNA (Fig. 2B),
unlike a derivative thereof that carried four
mutations disrupting annealing of the small
RNA. Moreover, translation inhibition by
miR-32 was suppressed in P19-expressing
cells (fig. S2).
The miR-32 target is in open reading frame
(ORF) 2, shared by the Bet and EnvBet
proteins, and is also within the 3UTR of all
remaining PFV-1 mRNAs (Fig. 2A). To ad-
dress the antiviral effect of miR-32, we used
antisense locked nucleic acid (LNA) oligo-
nucleotides (fig. S3), which yield highly stable
hybrids (14). In HeLa and BHK-21 cells, the
transfected anti-miR-32 LNA prevented
translation inhibition by miR-32, whereas a
control LNA with antisense sequence of the
unrelated miR-23 did not (fig. S3). At LNA
concentrations of 10 nM, accumulation of
PFV-1 mRNAs was higher in the anti-miR-
32–treated cells than in the anti-miR-23–
treated cells (Fig. 2C). Use of a luciferase-
based assay also indicated that the anti-
miR-32, unlike the anti-miR-23, almost
doubled progeny virus production (Fig. 2D).
Although these results are consistent with
an antiviral effect of miR-32, we could not
discard the possibility of an indirect action of
anti-miR-32 LNA causing, for instance,
ectopic expression of cellular miR-32 targets,
which could in turn increase viral fitness. The
miR-32 target sequence in PFV-1 was thus
modified to contain two synonymous muta-
tions that abolished the miR-32 pairing
but preserved the Bet amino acid content
(Fig. 2E). The mRNA levels from the miR-
32–resistant virus (PFV-1D32) were three
times as high as those from the unmodified
virus, consistent with the anti-miR-32 re-
sults (Fig. 2, E and C). Therefore, miR-32 ex-
erts a direct, sequence-specific effect against
PFV-1.
Does PFV-1 encode a silencing suppres-
sor to counter the antiviral effect of miR-32?
The constitutive presence of miR-32 required
that the putative suppressor be synthesized
precociously, which is the case of the Tas and
Bet proteins (Fig. 2A). As Bet is dispensable
for productive replication, Tas appears the
most likely candidate (15). miR-32–mediated
translational inhibition was indeed suppressed
in Tas-expressing BHK21 cells (Fig. 3A). This
was not specific for the sequence or activity
of miR-32, because Tas, like P19, also sup-
pressed endonucleolytic cleavage of GFP sen-
sors carrying a perfect miR-23 target (Fig. 3B
and fig. S2). Probably as a consequence of its
suppressor function, Tas promoted the nonspe-
cific overaccumulation of all cellular miRNAs
inspected, which we also observed 5 days after
PFV-1infectioninBHK21cells(Fig.3C).
miRNA overaccumulation is also seen with
several plant viral suppressors that interfere
with the miRNA pathway (3, 4).
To validate the silencing suppression
activity of Tas in a heterologous system, we
used an Arabidopsis line expressing an RNA
interference (RNAi) construct targeted against
chalcone synthase (CHS), which is responsible
for the brown seed-coat pigmentation (4). This
line accumulates CHS siRNAs and, conse-
Fig. 4. (A) Transgenic Tas suppresses CHS RNAi in Arabidopsis.(B) Northern analysis of CHS
siRNAs in two independent Tas-expressing lines. Col0, nontransformed plants; CHS, the reference
RNAi line. (C) Developmental defects and (D) miRNA accumulation in Tas-expressing Arabidopsis.
miR156 and miR172 are evolutionarily conserved miRNAs that promote cleavage and translation
inhibition, respectively. miR163 is a cleavage-promoting, Arabidopsis-specific miRNA.
Fig. 3. Tas suppresses miRNA-directed silencing in mammalian cells. (A) The reporter constructs
used in Fig. 2B were transected in control BHK21 cells (mock) or in cells stably expressing Tas. GFP
expression was assayed by Western analysis (top) 48 hours after transfection. Tas expression was
confirmed by Northern analysis (bottom). (B) A sequence with 100% complementarity to miR-23
(þ) or a mutated derivative thereof (–) was inserted into the 3UTR of the GFP reporter gene.
Constructs were transfected in BHK21 cells (mock) or in cells stably expressing Tas (Tas), and the
GFP mRNA was assayed by Northern analysis 48 hours later. (C) Northern analysis of cellular
miRNAs from BHK21 cells expressing (þ) or not expressing (–) Tas (left) and from noninfected (–)
or PFV-1–infected (þ) BHK21 cells (right). Total RNA was extracted 5 days after infection.
R EPORTS
www.sciencemag.org SCIENCE VOL 308 22 APRIL 2005
559
quently, produces pale yellow seeds (Fig.
4A, left). Transgenic Tas expression restored
anthocyanin synthesis (Fig. 4A, right) because
of a strong decrease in CHS siRNA levels
(Fig. 4B). Tas-expressing plants also ex-
hibited developmental anomalies, including
leaf elongation and serration (Fig. 4C),
reminiscent of those elicited in Arabidopsis
by viral suppressors interfering with miRNA
functions (3, 4). As in mammalian cells, Tas
enhanced miRNA accumulation (Fig. 4D),
independently of their nature or mode of
action, suggesting that it suppresses a fun-
damental step shared between the miRNA and
siRNA pathways that is conserved from plants
to mammals.
These results indicate that RNA silencing
limits the replication of a mammalian virus,
PFV-1, and that a cellular miRNA contrib-
utes substantially to this response. As a coun-
terdefense, PFV-1 produces Tas, a broadly
effective silencing suppressor. Because all
our experiments were conducted with Tas-
expressing viruses, because of the essential role
of the protein for replication (15), the strong
effect of Tas on siRNA accumulation observed
in Arabidopsis could account for our failure to
detect siRNAs in mammalian cells (fig. S1).
Therefore, we do not yet rule out their impli-
cation in the antiviral response reported here.
Our findings with miR-32 and PFV-1 were
in fact anticipated in plants by Llave, who
pointed out several near-perfect homologies
between Arabidopsis small RNAs and viral
genomes (16). The chances of a match be-
tween cellular miRNAs and foreign (i.e.,
viral) RNAs increase proportionally with the
size of sampled sequences. The extent to
which cellular miRNAs will be selected to
target pathogen genomes upon their initial
interaction with viruses may vary. En-
dogenous viruses might effectively coevolve
with miRNAs for defensive or developmen-
tal purposes (17, 18), such that viral control
might eventually constitute the sole function
of some cellular miRNAs. Exogenous viruses
with high mutation rates could, on the other
hand, rapidly escape this miRNA interference
through modification of the small RNA com-
plementary regions (19).
Our results support the emerging notion that
miRNAs might be broadly implicated in viral
infection of mammalian cells, with either posi-
tive or negative effects on replication (5, 20).
They also indicate that virtually any miRNA
has fortuitous antiviral potential, independent-
ly of its cellular function. Moreover, because
the repertoire of expressed miRNAs likely
varies from one cell type to another (11), this
phenomenon could well explain some of the
differences in viral permissivity observed be-
tween specific tissues.
Note added in proof: Recent findings
indicate that a single 8-oligonucleotide seed
(small RNA positions 1 to 8 from the 5 end)
is sufficient to confer strong regulation by
animals miRNAs. Thus, fortuitous targeting
of foreign RNAs by cellular miRNAs could
be widespread (21, 22).
References and Notes
1. A. J. Hamilton, D. C. Baulcombe, Science 286, 950
(1999).
2.H.Li,W.X.Li,S.W.Ding,Science 296, 1319
(2002).
3. K. D. Kasschau et al., Dev. Cell 4, 205 (2003).
4. P. Dunoyer, C. H. Lecellier, E. A. Parizotto, C. Himber,
O. Voinnet, Plant Cell 16, 1235 (2004).
5. S. Pfeffer et al., Science 304, 734 (2004).
6. W. X. Li et al., Proc. Natl. Acad. Sci. U.S.A. 101, 1350
(2004).
7. V. Schramke, R. Allshire, Curr. Opin. Genet. Dev. 14,
174 (2004).
8. M. Heinkelein et al., EMBO J. 19, 3436 (2000).
9. K. Ye, L. Malinina, D. J. Patel, Nature 426, 874
(2003).
10. J. M. Vargason, G. Szittya, J. Burgyan, T. M. Tanaka
Hall, Cell 115, 799 (2003).
11. D. P. Bartel, Cell 116, 281 (2004).
12. M. Kiriakidou et al., Genes Dev. 18, 1165 (2004).
13. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, T. Tuschl,
Science 294, 853 (2001).
14. J. S. Jepsen, M. D. Sorensen, J. Wengel, Oligonucleo-
tides 14, 130 (2004).
15. G. Baunach, B. Maurer, H. Hahn, M. Kranz, A. Rethwilm,
J. Virol. 67, 5411 (1993).
16. C. Llave, Mol. Plant Pathol. 5, 361 (2004).
17. H. Seitz et al., Nat. Genet. 34, 261 (2003).
18. S. Mi et al., Nature 403, 785 (2000).
19. A. T. Das et al., J. Virol. 78, 2601 (2004).
20. S. Lu, B. R. Cullen, J. Virol. 78, 12868 (2004).
21. J. Brennecke et al., PLoS Biol. 15, e85 (2005).
22. B. Lewis, C. Burge, D. Bartel, Cell 120, 15 (2005).
23. We thank S. W. Ding, B. Cullen, and P. Zamore for
critical reading of the manuscript and access to
data; members of the Voinnet lab for discussions;
and R. Wagner’s team for excellent plant care. Sup-
ported by an Action The
´
matique Incitative sur
Programme from the CNRS, the Fondation pour
la Recherche Me
´
dicale, and the Universite
´
Louis
Pasteur, Strasbourg.
Supporting Online Material
www.sciencemag.org/cgi/content/full/308/5721/557/
DC1
Materials and Methods
Figs. S1 to S4
References and Notes
16 December 2004; accepted 8 February 2005
10.1126/science.1108784
Postsecretory Hydrolysis of
Nectar Sucrose and Specialization
in Ant/Plant Mutualism
M. Heil,
*
J. Rattke, W. Boland
Obligate Acacia ant plants house mutualistic ants as a defense mechanism
and provide them with extrafloral nectar (EFN). Ant/plant mutualisms are
widespread, but little is known about the biochemical basis of their species
specificity. Despite its importance in these and other plant/animal inter-
actions, little attention has been paid to the control of the chemical com-
position of nectar. We found high invertase (sucrose-cleaving) activity in
Acacia EFN, which thus contained no sucrose. Sucrose, a disaccharide common
in other EFNs, usually attracts nonsymbiotic ants. The EFN of the ant acacias
was therefore unattractive to such ants. The Pseudomyrmex ants that are
specialized to live on Acacia had almost no invertase activity in their digestive
tracts and preferred sucrose-free EFN. Our results demonstrate postsecretory
regulation of the carbohydrate composition of nectar.
Many plants produce nectar in their flowers
(floral nectar) and on vegetative parts Eextrafloral
nectar (EFN)^ to mediate their interactions
with animals. The chemical composition of
nectar strongly affects the identity and behav-
ior of the attracted insects and thus the out-
come of the interaction (1–3). Particularly
important chemical factors include amino
acid content (4–6) and the ratio and amount
of the main sugars: glucose, fructose, and
sucrose (3). However, previous studies have
focused on nectar as a Bstanding crop,[ leav-
ing open the question of how its chemical
composition is controlled.
Floral nectar is produced to attract polli-
nators, whereas EFN acts to defend plants
indirectly Esee (7) for a description of EFN in
more than 80 plant families^.Mostinter-
actions among animals and both floral and
extrafloral nectars are thus believed to be
mutualistic. Highly specialized mutualisms
are surprisingly rare in nature, because they
are associated with specific coevolutionary
problems (8). In mutualisms in general, one
partner provides a service for the other and
receives some kind of reward (9). In defen-
sive ant/plant mutualisms, the presence of
ants serves as an indirect defense mechanism
and, in return, they receive food rewards and/
or nesting space (10).
Ant/plant mutualisms differ widely in their
specificity and thus are particularly suitable for
Department of Bioorganic Chemistry, Max-Planck-
Institute for Chemical Ecology, Hans-Kno
¨
ll-Strasse 8,
D-07745 Jena, Germany.
*To whom correspondence should be addressed at FB 9
BioGeo-Allgemeine Botanik/Pflanzeno
¨
kologie, Universi-
ty of Duisburg-Essen, Universita
¨
tsstraße 5, D-45117
Essen, Germany. E-mail: Heil_Martin@web.de
R EPORTS
22 APRIL 2005 VOL 308 SCIENCE www.sciencemag.org
560
... p19 binds RNA sequences with size selectivity 26,27 . Rational design and protein engineering of the p19 VSRS has allowed the development of biotechnological tools with diverse applications 17,27,28,[31][32][33][34][35][36][37] . p19 has proved to be a potent inhibitor of small RNA function, which opens the door to further engineering the protein to exhibit "super suppressor" activity with added endonuclease functionality 17,[33][34][35][36] . ...
... Rational design and protein engineering of the p19 VSRS has allowed the development of biotechnological tools with diverse applications 17,27,28,[31][32][33][34][35][36][37] . p19 has proved to be a potent inhibitor of small RNA function, which opens the door to further engineering the protein to exhibit "super suppressor" activity with added endonuclease functionality 17,[33][34][35][36] . Previously, it has been shown that using the pioneering technologies of genetic code expansion in combination with unnatural amino acids (UAAs), different organisms can code for more than the 20 canonical amino acids allowing for the incorporation of unique chemical side chains into the desired location in a protein of interest [38][39][40] . ...
... From the Nanostring profiling experiment, it is evident that other miRNAs exhibit a higher degree of cleavage, which can potentially be attributed to the enhanced binding of p19 mutant to these miRNAs. The differences in affinity could be attributed to the mismatches in the miRNA sequences, which create bulges in the secondary structure of the miRNA, thus affecting the potential binding affinity to p19, depending on the location of the bulge 27,35,46 . ...
Article
Full-text available
Endonucleases are enzymes that cleave internal phosphodiester bonds within double-stranded DNA or RNA and are essential for biological functions. Herein, we use genetic code expansion to create an unnatural endonuclease that cleaves non-coding RNAs including short interfering RNA (siRNA) and microRNAs (miRNAs), a function that does not exist in nature. We introduce a metal-chelating unnatural amino acid, (2,2′-bipyridin-5-yl)alanine (BpyAla) to impart endonuclease activity to the viral suppressor of RNA silencing protein p19. Upon binding of copper, the mutant p19-T111BpyAla displays catalytic site-specific cleavage of siRNA and human miRNAs. Catalysis is confirmed using fluorescence polarization and fluorescence turn-on. Global miRNA profiling reveals that the engineered enzyme cleaves miRNAs in a human cell line. The therapeutic potential is demonstrated by targeting miR-122, a critical host factor for the hepatitis C virus (HCV). Unnatural endonuclease function is shown to deplete miR-122 levels with similar effects to an antagomir that reduces HCV levels therapeutically.
... MicroRNAs (miRNAs) have been explored as a potential therapeutic approach to inhibit the replication of viruses such as hepatitis C virus (HCV) [11], primate foamy virus type 1 (PFV-1) [19], and vesicular stomatitis virus (VSV) [28]. Some miRNAs related to HBV have also been discovered, such as miR-192-3p, which can promote HBV replication by inhibiting Akt/mTOR signalling [21]. ...
Article
Full-text available
To date, effective medication against hepatitis B virus (HBV) has not been developed. MicroRNAs (miRNAs) comprise a promising therapeutic approach to inhibit the virus. In this study, 1917 miRNAs in the miRBase database were screened using bioinformatics software to obtain candidates that can target HBV genotype B. Two parameters, namely pairing pattern and minimum free energy were used to select the qualifying miRNAs. Three miRNAs targeting the X gene and one miRNA targeting the C gene were identified out of 39 initial candidates. Uniquely, miR-6770-5p was the only candidate that could target the X gene of all HBV genotypes, with a higher potency of inhibition compared to other candidates. The three other candidates also showed good potency for some genotypes; thus, the identified candidates show promise as therapeutics for hepatitis infection.
... This implies that miR-1307-3p may instead have a detrimental effect on the virus, as our data supports that the virus preferentially evolved to reduce this interaction. Recent work has identified that host miRs may target the viral genome as part of the immune response, in which case, the virus would preferentially evolve to evade this attack (Skalsky and Cullen 2010;Huang et al. 2007;Lecellier et al. 2005;Otsuka et al. 2007). ...
Article
The stem loop 2 motif (s2m), a highly conserved 41-nucleotide hairpin structure in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome, serves as an attractive therapeutic target that may have important roles in the virus life cycle or interactions with the host. However, the conserved s2m in Delta SARS-CoV-2, a previously dominant variant characterized by high infectivity and disease severity, has received relatively less attention than that of the original SARS-CoV-2 virus. The focus of this work is to identify and define the s2m changes between Delta and SARS-CoV-2 and subsequent impact of those changes upon the s2m dimerization and interactions with the host microRNA miR-1307-3p. Bioinformatics analysis of the Global Initiative on Sharing All Influenza Data (GISAID) database targeting the s2m element reveals a greater than 99% correlation of a single nucleotide mutation at the 15th position (G15U) in Delta SARS-CoV-2. Based on 1H NMR spectroscopy assignments comparing the imino proton resonance region of s2m and the s2m G15U at 19°C, we show that the U15-A29 base pair closes resulting in a stabilization of the upper stem without overall secondary structure deviation. Increased stability of the upper stem did not affect the chaperone activity of the viral N protein, as it was still able to convert the kissing dimers formed by s2m G15U into a stable duplex conformation, consistent with the s2m reference. However, we find that the s2m G15U mutation drastically impacts the binding of the host miR-1307-3p. These findings demonstrate that the observed G15U mutation alters the secondary structure of s2m with subsequent impact on viral binding of host miR-1307-3p, with potential consequences on the immune response.
... A cellular miRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses miRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities (Lecellier et al 2005). Therefore, through fortuitous recognition of foreign nucleic acids, cellular miRNAs have direct antiviral effects in addition to their regulatory functions. ...
Technical Report
Full-text available
RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy complementary RNA. The report compares RNAi with other antisense approaches using oligonucleotides, aptamers, ribozymes, peptide nucleic acid and locked nucleic acid. Various RNAi technologies are described, along with design and methods of manufacture of siRNA reagents. These include chemical synthesis by in vitro transcription and use of plasmid or viral vectors. Other approaches to RNAi include DNA-directed RNAi (ddRNAi) that is used to produce dsRNA inside the cell, which is cleaved into siRNA by the action of Dicer, a specific type of RNAse III. MicroRNAs are derived by processing of short hairpins that can inhibit the mRNAs. Expressed interfering RNA (eiRNA) is used to express dsRNA intracellularly from DNA plasmids. Delivery of therapeutics to the target tissues is an important consideration. siRNAs can be delivered to cells in culture by electroporation or by transfection using plasmid or viral vectors. In vivo delivery of siRNAs can be carried out by injection into tissues or blood vessels or use of synthetic and viral vectors. Because of its ability to silence any gene once the sequence is known, RNAi has been adopted as the research tool to discriminate gene function. After the genome of an organism is sequenced, RNAi can be designed to target every gene in the genome and target for specific phenotypes. Several methods of gene expression analysis are available and there is still need for sensitive methods of detection of gene expression as a baseline and measurement after gene silencing. RNAi microarray has been devised and can be tailored to meet the needs for high throughput screens for identifying appropriate RNAi probes. RNAi is an important method for analyzing gene function and identifying new drug targets that uses double-stranded RNA to knock down or silence specific genes. With the advent of vector-mediated siRNA delivery methods it is now possible to make transgenic animals that can silence gene expression stably. These technologies point to the usefulness of RNAi for drug discovery. RNAi can be rationally designed to block the expression of any target gene, including genes for which traditional small molecule inhibitors cannot be found. Areas of therapeutic applications include virus infections, cancer, genetic disorders and neurological diseases. Research at academic centers that is relevant to RNAi-based therapeutics is mentioned. Regulatory, safety and patent issues are discussed. Side effects can result from unintended interaction between an siRNA compound and an unrelated host gene. If RNAi compounds are designed poorly, there is an increased chance for non-specific interaction with host genes that may cause adverse effects in the host. However, there are no major safety concerns and regulations are in preliminary stages as the clinical trials are still ongoing and there are no marketed products. Many of the patents are still pending. The markets for RNAi are difficult to define as no RNAi-based product is approved yet but several are in clinical trials. The major use of RNAi reagents is in research but it partially overlaps that of drug discovery and therapeutic development. Various markets relevant to RNAi are analyzed from 2020 to 2030. Markets are also analyzed according to technologies and use of siRNAs, miRNAs, etc. Profiles of 168 companies involved in developing RNAi technologies are presented along with 231 collaborations. They are a mix of companies that supply reagents and technologies (nearly half of all) and companies that use the technologies for drug discovery. Out of these, 34 are developing RNAi-based therapeutics and 36 are involved in microRNAs. The bibliography contains selected 650 publications that are cited in the report. The text is supplemented with 39 tables and 18 figures.
... A cellular miRNA effectively restricts the accumulation of the retrovirus primate foamy virus type 1 (PFV-1) in human cells. PFV-1 also encodes a protein, Tas, that suppresses miRNA-directed functions in mammalian cells and displays cross-kingdom antisilencing activities (Lecellier et al 2005). Therefore, through fortuitous recognition of foreign nucleic acids, cellular miRNAs have direct antiviral effects in addition to their regulatory functions. ...
Technical Report
Full-text available
This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their commercial importance. Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections. Expert opinion is given about the current problems and needs in antiviral therapy. SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent. A novel feature of this report is the use of nanotechnology in virology and its potential for antiviral therapeutics. Interaction of nanoparticles with viruses are described. NanoViricides are polymeric micelles, which act as nanomedicines to destroy viruses. Various methods for local as well as systemic delivery of antiviral agents and vaccines are described. Nanobiotechnology plays an important role in improving delivery of antivirals. Advantages and limitations of delivery of gene-based, antisense and RNAi antiviral therapeutics are discussed. Anti-influenza measures applicable to human as well as avian forms are described including the recent epidemic of swine flu. Resistance can develop against neuraminidase inhibitors although it is less than that with adamantanes. Considering these problems, there is need for a more effective agent. Investigations into alternative anti-influenza target will probably expand in the coming years. These include the development of mechanisms to inhibit fusion between the virus envelope and the cell membrane. After a discussion of current therapies of AIDS/HIV and their limitations, new strategies in development of antiviral agents are described. Drug resistance and toxicities are emerging as major treatment challenges. Based on a review of technologies and drugs in development, it can be stated that there are good prospects are of finding a cure for HIV/AIDS in the next decade. Hepatitis viruses are described with focus on hepatitis C virus (HCV) and hepatitis B virus (HBV). Despite the presence of numerous drug candidates in the anti-HCV pipeline, and the commitment of major R&D resources by many pharmaceutical companies, it might still take several years for any new anti-HCV drugs to reach the market. Although many companies are focusing their efforts on developing viral inhibitors, cellular targets in the host are beginning to emerge as attractive possibilities because they might enable the development of broad-spectrum antiviral drugs with less chance for developing viral resistance. Various commercially important viruses include herpes simplex (HSV) and human papilloma virus (HPV). There a number of treatments but HSV is not destroyed completely and remains dormant and activates from time to time to cause various clinical manifestations. There is discussion about the role of HPV in cervical cancer and vaccines available now seem to be adequate in preventing HSV-induced cervical cancer. There is no effective vaccine for respiratory syncytial virus (RSV) although monoclonal antibody (MAb) treatment is useful for prophylaxis and reducing the clinical manifestations. There is a need for an agent to eliminate this virus. Various viruses that either occur in epidemics or in tropics and some naturally emerging infectious diseases are described, e.g. viral hemorrhagic fevers such as dengue and West Nile virus infection. These are a constant threat and impossible to anticipate. Some of these lack antiviral agents or vaccines for prevention. Although these include some of the most serious viral disorders, the development of antiviral agents for these is not commercially attractive. Current research and approaches to these virus infections, particularly the current pandemic of COVID-19, are discussed. There are over 110 drugs and vaccine candidates in development of which 3 have been approved by the FDA and other health authorities around the world. Vaccination is being carried out in several countries Markets for antivirals are considered according to viruses and diseases caused by them and also according to management approaches: antiviral drugs, vaccines, MAbs and innovative approaches that include immunological and use of other technologies such as gene therapy, antisense, RNAi and nanobiotechnology. Antiviral markets are estimated starting with 2020 with projections up to the year 2030. Profiles of 197 companies that are involved in developing various technologies and products are profiled and with 182 collaborations. These include major pharmaceutical companies (12), Biopharmaceutical companies with antiviral products (87), Antiviral drug companies (26) as well as viral vaccine companies (71). The report is supplemented with 58 tables, 17 figures and 550 references from the literature.
... This implies that miR-1307-3p may instead have a detrimental effect on the virus, as our data supports that the virus preferentially evolved to reduce this interaction. Recent work has identified that host miRs may target the viral genome as part of the immune response, in which case, the virus would preferentially evolve to evade this attack (Skalsky and Cullen 2010;Huang et al. 2007;Lecellier et al. 2005;Otsuka et al. 2007). MiRs normally bind to the target mRNA 3'-UTR to signal its degradation and/or to regulate its translation (O'Brien et al. 2018). ...
Preprint
Full-text available
The stem loop 2 motif (s2m), a highly conserved 41-nucleotide hairpin structure in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome, serves as an attractive therapeutic target that may have important roles in the virus life cycle or interactions with the host. However, the conserved s2m in Delta SARS-CoV-2, a previously dominant variant characterized by high infectivity and disease severity, has received relatively less attention than that of the original SARS-CoV-2 virus. The focus of this work is to identify and define the s2m changes between Delta and SARS-CoV-2 and subsequent impact of those changes upon the s2m dimerization and interactions with the host microRNA miR-1307-3p. Bioinformatics analysis of the GISAID database targeting the s2m element reveals a greater than 99% correlation of a single nucleotide mutation at the 15th position (G15U) in Delta SARS-CoV-2. Based on 1H NMR assignments comparing the imino proton resonance region of s2m and the G15U at 19°C, we find that the U15-A29 base pair closes resulting in a stabilization of the upper stem without overall secondary structure deviation. Increased stability of the upper stem did not affect the chaperone activity of the viral N protein, as it was still able to convert the kissing dimers formed by s2m G15U into a stable duplex conformation, consistent with the s2m reference. However, we find that the s2m G15U mutation drastically reduces the binding affinity of the host miR-1307-3p. These findings demonstrate that the observed G15U mutation alters the secondary structure of s2m with subsequent impact on viral binding of host miR-1307-3p, with potential consequences on the immune response.
... Small sample sizes for RT-qPCR validation and technological errors may partially account for variations in miR-let-7f quantification. Deregulation of hsa-miR-32-5p effectively limited the accumulation of the primate foamy virus type 1 (PFV-1) retrovirus in human cells [51]. To the best of our knowledge, the biological role of hsa-miR-32-5p in HAM/TSP has not been investigated. ...
Preprint
Human T-lymphotropic virus type 1 (HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a slowly progressive spinal cord disorder with no effective treatment. There is much of interest in developing potential biomarkers for predicting the pathogenesis of HAM/TSP disorder. This study used Illumina massive parallel sequencing (MPS) technology to assess the cellular global noncoding RNAome expression profile in HAM/TSP patients (n = 10), asymptomatic HTLV-1 infected carriers (ASP, n = 8), and a second group of healthy controls (n = 5). Using various bioinformatics tools, the sRNA MPS reads were aligned, annotated, and profiled. There were 251 known and 50 potential novel sRNAs among the 402 detected sRNAs in the HAM and ASP groups versus the HC group. Sixty-eight known sRNAs were found to be significantly different between the ASP and HAM groups. In HAM vs ASP subjects, 88 mature miRNAs were downregulated. Three of these miRs (hsa-miR-185-5p, 32-5p, and 192-5p) have the potential to be used as biomarkers for predicting the pathogenesis of HAM/TSP. The top seven deregulated miRS target genes were linked to a variety of biological processes and molecular functions. Relevant reactome pathways to our findings provide a rich source of data and an opportunity to further understand sRNA regulation and function in HTLV-1 pathophysiology.
... On the one hand, RNA interference promotes the defence of viruses in many multicellular organisms [78,79]. On the other hand, some mammalian viruses were shown to benefit from the RNAi machinery of their host [80]. Interestingly, part of the host miRNAs can enhance virus replication. ...
Article
Full-text available
Prostate cancer is the most common cancer and one of the leading causes of cancer mortality in males. Androgen-deprivation therapy (ADT) is an effective strategy to inhibit tumour growth at early stages. However, 10~50% of cases are estimated to progress to metastatic castration-resistant prostate cancer (mCRPC) which currently lacks effective treatments. Clinically, salvage treatment measures, such as endocrine therapy and chemotherapy, are mostly used for advanced prostate cancer, but their clinical outcomes are not ideal. When the existing clinical therapeutic methods can no longer inhibit the development of advanced prostate cancer, human adenovirus (HAdV)-based gene therapy and viral therapy present promising effects. Pre-clinical studies have shown its powerful oncolytic effect, and clinical studies are ongoing to further verify its effect and safety in prostate cancer treatment. Targeting the prostate by HAdV alone or in combination with radiotherapy and chemotherapy sheds light on patients with castration-resistant and advanced prostate cancer. This review summarizes the advantages of oncolytic virus-mediated cancer therapy, strategies of HAdV modification, and existing preclinical and clinical investigations of HAdV-mediated gene therapy to further evaluate the potential of oncolytic adenovirus in prostate cancer treatment.
Article
MicroRNAs (miRNAs) are small non-coding RNAs known to play a significant role in the regulation of gene expression in various living organisms including fish. MiR-155 is known to enhance immunity in cells and several reports have demonstrated the antiviral properties of miR-155 in mammals. In this study, we investigated the antiviral role of miR-155 in Epithelioma papulosum cyprini (EPC) cells with viral hemorrhagic septicemia virus (VHSV) infection. EPC cells were transfected with miR-155 mimic and then infected with VHSV at different MOIs (0.01 and 0.001). The cytopathogenic effect (CPE) was observed at 0, 24, 48, and 72 h post infection (h.p.i). CPE progression appeared at 48 h.p.i in mock groups (VHSV only infected groups) and the VHSV infection group transfected with miR-155 inhibitors. On the other hand, the groups transfected with the miR-155 mimic did not show any CPE formation after infection with VHSV. The supernatant was collected at 24, 48 and 72 h.p.i., and the viral titers were measured by plaque assay. The viral titers increased at 48 and 72 h.p.i in groups infected only with VHSV. In contrast, the groups transfected with miR-155 did not show any increase in the virus titer and had a similar titer to 0 h.p.i. Furthermore, the real-time RT-PCR of immune gene expression showed upregulation of Mx1 and ISG15 at 0, 24, and 48 h.p.i in groups transfected with miR-155, while the genes were upregulated at 48 h.p.i in groups infected only with VHSV. Based on these results, miR-155 can induce the overexpression of type I interferon-related immune genes in EPCs and inhibit the viral replication of VHSV. Therefore, these results suggest that miR-155 could possess an antiviral effect against VHSV.
Presentation
Full-text available
Introduction to miRBase database
Article
Full-text available
MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression in plants and animals. Although their biological importance has become clear, how they recognize and regulate target genes remains less well understood. Here, we systematically evaluate the minimal requirements for functional miRNA-target duplexes in vivo and distinguish classes of target sites with different functional properties. Target sites can be grouped into two broad categories. 5' dominant sites have sufficient complementarity to the miRNA 5' end to function with little or no support from pairing to the miRNA 3' end. Indeed, sites with 3' pairing below the random noise level are functional given a strong 5' end. In contrast, 3' compensatory sites have insufficient 5' pairing and require strong 3' pairing for function. We present examples and genome-wide statistical support to show that both classes of sites are used in biologically relevant genes. We provide evidence that an average miRNA has approximately 100 target sites, indicating that miRNAs regulate a large fraction of protein-coding genes and that miRNA 3' ends are key determinants of target specificity within miRNA families.
Article
Full-text available
Foamy viruses belong to the retroviruses which possess a complex genome structure. The human foamy virus (HFV) isolate bears three open reading frames (the so-called bel genes) in the 3' region of the genome which have been reported to give rise to possibly six different proteins via alternative splicing (W. Muranyi and R. M. Flügel, J. Virol. 65:727-735, 1991). In order to analyze the requirements of these proteins for HFV replication in vitro, we constructed a set of single and combinatory bel gene mutants of an infectious molecular clone of HFV. The mutant which lacked the transacting activator, bel-1, was found to be replication incompetent. All other mutants replicated equally well and gave rise to comparable titers of infectious cell-free virus. When HFV proviruses were put under the control of a heterologous promoter (simian virus 40), none of the accessory gene products was found to be required for expression of structural (gag) proteins. There was no evidence for a posttranscriptional regulatory protein that is present in other complex retroviruses.
Article
Full-text available
Many mammalian viruses have acquired genes from their hosts during their evolution. The rationale for these acquisitions is usually quite clear: the captured genes are subverted to provide a selective advantage to the virus. Here we describe the opposite situation, where a viral gene has been sequestered to serve an important function in the physiology of a mammalian host. This gene, encoding a protein that we have called syncytin, is the envelope gene of a recently identified human endogenous defective retrovirus, HERV-W. We find that the major sites of syncytin expression are placental syncytiotrophoblasts, multinucleated cells that originate from fetal trophoblasts. We show that expression of recombinant syncytin in a wide variety of cell types induces the formation of giant syncytia, and that fusion of a human trophoblastic cell line expressing endogenous syncytin can be inhibited by an anti-syncytin antiserum. Our data indicate that syncytin may mediate placental cytotrophoblast fusion in vivo, and thus may be important in human placental morphogenesis.
Article
Full-text available
The foamy virus (FV) subgroup of Retroviridae reverse transcribe their RNA (pre-)genome late in the replication cycle before leaving an infected cell. We studied whether a marker gene-transducing FV vector is able to shuttle to the nucleus and integrate into host cell genomic DNA. While a potential intracellular retrotransposition of vectors derived from other retroviruses was below the detection limit of our assay, we found that up to 5% of cells transfected with the FV vector were stably transduced, harboring 1 to approximately 10 vector integrants. Generation of the integrants depended on expression of functional capsid, reverse transcriptase and integrase proteins, and did not involve an extracellular step. PCR analysis of the U3 region of the 5' long terminal repeat and determination of proviral integration sites showed that a reverse transcription step had taken place to generate the integrants. Co-expression of a mutated envelope allowing particle egress and avoiding extracellular infection resulted in a significantly increased rescue of cells harboring integrants, suggesting that accumulation of proviruses via intracellular retrotransposition represents an integral part of the FV replication strategy.
Article
SUMMARY Eukaryotic small RNA comprises several classes of 21-25 nucleotide non-coding RNA, of which microRNA (miRNA) has gained a great deal of attention because it is directly involved in controlling growth and development in plants. miRNAs are processed by the RNase III-like Dicer, although recent studies have implicated additional gene products in the step-wise maturation of miRNAs from their primary nuclear transcripts. They function as sequence-specific guides to trigger cleavage or translational repression of target mRNAs that have complementary sequences. Natural miRNA targets encode members of large families of transcription factors, which are collectively required for a number of developmental processes. In addition to developmental regulation, some miRNAs might be involved in specific physiological responses to several types of stresses, such as those induced by pathogen infections. Strikingly, the potyviruses, the largest group of plant RNA viruses, are able to interfere with miRNA-guided cleavage of multiple regulatory targets in plants, thus modulating gene expression of the host cell.
Article
Posttranscriptional gene silencing (PTGS) is a nucleotide sequence-specific defense mechanism that can target both cellular and viral mRNAs. Here, three types of transgene-induced PTGS and one example of virus-induced PTGS were analyzed in plants. In each case, antisense RNA complementary to the targeted mRNA was detected. These RNA molecules were of a uniform length, estimated at 25 nucleotides, and their accumulation required either transgene sense transcription or RNA virus replication. Thus, the 25-nucleotide antisense RNA is likely synthesized from an RNA template and may represent the specificity determinant of PTGS.
Article
In Caenorhabditis elegans, lin-4 and let-7 encode 22- and 21-nucleotide (nt) RNAs, respectively, which function as key regulators of developmental timing. Because the appearance of these short RNAs is regulated during development, they are also referred to as small temporal RNAs (stRNAs). We show that many 21- and 22-nt expressed RNAs, termed microRNAs, exist in invertebrates and vertebrates and that some of these novel RNAs, similar to let-7 stRNA, are highly conserved. This suggests that sequence-specific, posttranscriptional regulatory mechanisms mediated by small RNAs are more general than previously appreciated.
Article
RNA silencing is a sequence-specific RNA degradation mechanism that is operational in plants and animals. Here, we show that flock house virus (FHV) is both an initiator and a target of RNA silencing in Drosophila host cells and that FHV infection requires suppression of RNA silencing by an FHV-encoded protein, B2. These findings establish RNA silencing as an adaptive antiviral defense in animal cells. B2 also inhibits RNA silencing in transgenic plants, providing evidence for a conserved RNA silencing pathway in the plant and animal kingdoms.
Article
The molecular basis for virus-induced disease in plants has been a long-standing mystery. Infection of Arabidopsis by Turnip mosaic virus (TuMV) induces a number of developmental defects in vegetative and reproductive organs. We found that these defects, many of which resemble those in miRNA-deficient dicer-like1 (dcl1) mutants, were due to the TuMV-encoded RNA-silencing suppressor, P1/HC-Pro. Suppression of RNA silencing is a counterdefensive mechanism that enables systemic infection by TuMV. The suppressor interfered with the activity of miR171 (also known as miRNA39), which directs cleavage of several mRNAs coding for Scarecrow-like transcription factors, by inhibiting miR171-guided nucleolytic function. Out of ten other mRNAs that were validated as miRNA-guided cleavage targets, eight accumulated to elevated levels in the presence of P1/HC-Pro. The basis for TuMV- and other virus-induced disease in plants may be explained, at least partly, by interference with miRNA-controlled developmental pathways that share components with the antiviral RNA-silencing pathway.